Biswanath De

1.9k citations

55 papers · 1.4k indexed · h-index 23

Co-authors: Michael J. Janusz Michael G. Natchus Neil G. Almstead Yetunde O. Taiwo E. J. Corey Stanisław Pikul Lily C. Hsieh Glen E. Mieling
Topics: Synthesis and biological activity (12 papers)Peptidase Inhibition and Analysis (11 papers)Protease and Inhibitor Mechanisms (11 papers)
Cited by: Cancer Research Organic Chemistry Oncology
Journals: Journal of the American Chemical Society Annals of the New York Academy of Sciences Journal of Medicinal Chemistry
Partner nations: United States United Kingdom

In The Last Decade

Biswanath De

54 papers receiving 1.3k citations

Peers

Countries citing papers authored by Biswanath De

Since Specialization

Citations

This map shows the geographic impact of Biswanath De's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biswanath De with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biswanath De more than expected).

Fields of papers citing papers by Biswanath De

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biswanath De. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biswanath De. The network helps show where Biswanath De may publish in the future.

Co-authorship network of co-authors of Biswanath De

This figure shows the co-authorship network connecting the top 25 collaborators of Biswanath De. A scholar is included among the top collaborators of Biswanath De based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biswanath De. Biswanath De is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of pyrimidine-based inhibitors of Janus tyrosine kinase 3 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jack J. Chen,Kumar Thakur,Michael P. Clark,(unknown),Kelly M. George,Roger G. Bookland,(unknown),(unknown),(unknown),Biswanath De,(unknown)	30
2	Development of N-4,6-pyrimidine-N-alkyl-N′-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jennifer A. Maier,Todd A. Brugel,M. Sabat,Adam Gołȩbiowski,Matthew J. Laufersweiler,John C. VanRens,Corey R. Hopkins,Biswanath De,Lily C. Hsieh,Kimberly K. Brown,(unknown),Michael J. Janusz	12
3	The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck) 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat,John C. VanRens,Matthew J. Laufersweiler,Todd A. Brugel,Jennifer Maier,Adam Gołȩbiowski,Biswanath De,(unknown),Lily C. Hsieh,Richard L. Walter,Marlene Mekel,A.G. Evdokimov,Michael J. Janusz	57
4	The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-α production 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat,John C. VanRens,Michael P. Clark,Todd A. Brugel,Jennifer Maier,Roger G. Bookland,Matthew J. Laufersweiler,(unknown),Adam Gołȩbiowski,Biswanath De,Lily C. Hsieh,Richard L. Walter,Marlene Mekel,Michael J. Janusz	11
5	Development of N-2,4-pyrimidine-N-phenyl-N′-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 1 2006 ·Bioorganic & Medicinal Chemistry Letters ·Todd A. Brugel,Jennifer A. Maier,Michael P. Clark,M. Sabat,Adam Gołȩbiowski,Roger G. Bookland,Matthew J. Laufersweiler,(unknown),John C. VanRens,Biswanath De,Lily C. Hsieh,Marlene Mekel,Michael J. Janusz	15
6	Synthesis and evaluation of novel 1-(2-acylhydrazinocarbonyl)-cycloalkyl carboxamides as interleukin-1β converting enzyme (ICE) inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Steven V. O’Neil,Yili Wang,Michael C. Laufersweiler,(unknown),John A. Wos,Christopher D. Ellis,(unknown),Wei Lü,Maureen K. Suchanek,(unknown),Biswanath De,Thomas Demuth	4
7	Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3) 2006 ·Bioorganic & Medicinal Chemistry Letters ·Michael P. Clark,Kelly M. George,Roger G. Bookland,Jack Chen,(unknown),Kumar Thakur,Wenlin Lee,(unknown),(unknown),Todd A. Brugel,John C. VanRens,Matthew J. Laufersweiler,Jennifer A. Maier,M. Sabat,Adam Gołȩbiowski,(unknown),(unknown),Biswanath De,George Zhang	50
8	The development of novel 1,2-dihydro-pyrimido[4,5-c]pyridazine based inhibitors of lymphocyte specific kinase (Lck) 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat,John C. VanRens,Todd A. Brugel,Jennifer Maier,Matthew J. Laufersweiler,Adam Gołȩbiowski,Biswanath De,(unknown),Lily C. Hsieh,(unknown),(unknown),Eric G. Suchanek,Michael J. Janusz	18
9	Discovery of novel conformationally restricted diazocan peptidomimetics as inhibitors of interleukin-1β synthesis 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Christopher D. Ellis,Michael C. Laufersweiler,Steven V. O’Neil,Yili Wang,(unknown),(unknown),John A. Wos,Biswanath De,(unknown),(unknown),Wei Lü,Maureen K. Suchanek,(unknown),(unknown)	18
10	The development of novel inhibitors of tumor necrosis factor-α (TNF-α) production based on substituted [5,5]-bicyclic pyrazolones 2004 ·Bioorganic & Medicinal Chemistry Letters ·Matthew J. Laufersweiler,Todd A. Brugel,Michael P. Clark,Adam Gołȩbiowski,Roger G. Bookland,(unknown),M. Sabat,(unknown),John C. VanRens,Biswanath De,Lily C. Hsieh,S.A. Heitmeyer,(unknown),Kimberly K. Brown,Marlene Mekel,Richard L. Walter,Michael J. Janusz	17
11	The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold 2001 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Matthew J. Laufersweiler,John C. VanRens,Michael G. Natchus,Roger G. Bookland,Neil G. Almstead,Stanisław Pikul,Biswanath De,Lily C. Hsieh,Michael J. Janusz,(unknown),Sean Peng,(unknown),Tomáš Hudlický,(unknown)	17
12	The Synthesis and Human FP Receptor Binding Affinity of 13,14-Dihydro Prostaglandin F1.ALPHA. Sulfonamides. Potential Treatments for Osteoporosis. 2000 ·Chemical and Pharmaceutical Bulletin ·Yili Wang,(unknown),(unknown),Mitchell A. deLong,Biswanath De,John A. Wos	25
13	Design and Synthesis of 13,14-Dihydro Prostaglandin F_1α Analogues as Potent and Selective Ligands for the Human FP Receptor 2000 ·Journal of Medicinal Chemistry ·Yili Wang,John A. Wos,(unknown),(unknown),Mitchell A. deLong,Glen E. Mieling,Biswanath De,Jack Amburgey,Eric G. Suchanek,Cynthia J. Taylor	5
14	The Next Generation of MMP Inhibitors: Design and Synthesis 1999 ·Annals of the New York Academy of Sciences ·Biswanath De,Michael G. Natchus,(unknown),Stanisław Pikul,Neil G. Almstead,Yetunde O. Taiwo,Catherine E. Snider,(unknown),(unknown),Fei Gu,Martin E. Dowty	28
15	Design, Synthesis, and Biological Evaluation of Matrix Metalloproteinase Inhibitors Derived from a Modified Proline Scaffold 1999 ·Journal of Medicinal Chemistry ·(unknown),Biswanath De,Neil G. Almstead,Stanisław Pikul,Martin E. Dowty,(unknown),C. Michelle Dunaway,Fei Gu,Lily C. Hsieh,Michael J. Janusz,Yetunde O. Taiwo,Michael G. Natchus,Tomáš Hudlický,Martin Mandel	45
16	Design and synthesis of conformationally-constrained MMP inhibitors 1998 ·Bioorganic & Medicinal Chemistry Letters ·Michael G. Natchus,(unknown),(unknown),Stanisław Pikul,Neil G. Almstead,(unknown),Yetunde O. Taiwo,Glen E. Mieling,C. Michelle Dunaway,Catherine E. Snider,(unknown),B.L. Barnett,(unknown),(unknown),Biswanath De	26
17	Cardiovascular Effects of Orally Administered ABBOTT-81988, an Angiotensin II Antagonist, in Conscious Spontaneously Hypertensive Rats 1994 ·American Journal of Hypertension ·(unknown),Robert B. Warner,Michael E. Brune,Andrew Adler,Martin Winn,Biswanath De,Thomas M. Zydowsky,Terry J. Opgenorth,Daniel J. Kerkman,John F. DeBernardis	2
18	2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists 1993 ·Journal of Medicinal Chemistry ·Martin Winn,Biswanath De,Thomas M. Zydowsky,Robert J. Altenbach,Fatima Z. Basha,Steven A. Boyd,Michael E. Brune,Steven A. Buckner,(unknown)	18
19	A non-azole inhibitor of lanosterol l4α-methy1 demethylase in Candida albicans 1992 ·Journal of Antimicrobial Chemotherapy ·John O. Capobianco,(unknown),Robert C. Goldman,Biswanath De	8
20	LH-RH antagonists: design and synthesis of a novel series of peptidomimetics 1989 ·Journal of Medicinal Chemistry ·Biswanath De,Jacob J. Plattner,Eugene N. Bush,(unknown),Gilbert Diaz,(unknown),Thomas J. Perun	26

About Biswanath De

Biswanath De is a scholar working on Cancer Research, Oncology and Organic Chemistry, having authored 55 papers that have together received 1.4k indexed citations. Recurring topics across this work include Synthesis and biological activity (12 papers), Peptidase Inhibition and Analysis (11 papers) and Protease and Inhibitor Mechanisms (11 papers). The work is most often cited by research in Cancer Research (331 citations), Organic Chemistry (596 citations) and Oncology (398 citations). Biswanath De has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Michael J. Janusz, Michael G. Natchus, Neil G. Almstead, Yetunde O. Taiwo, E. J. Corey, Stanisław Pikul, Lily C. Hsieh, Glen E. Mieling, Fei Gu and C. Michelle Dunaway. Their work appears in journals such as Journal of the American Chemical Society, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact